Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Gut and Liver|October 1, 2021
Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel DiseaseJi Min Lee, Shu-Chen Wei, Kang-Moon Lee, et al.Inflammatory Bowel Diseases|May 31, 2018
Establishment of a Novel Scoring System for Colon Capsule Endoscopy to Assess the Severity of Ulcerative Colitis-Capsule Scoring of Ulcerative ColitisNaoki Hosoe, Masaru Nakano, Ken Takeuchi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2022
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction TreatmentEdward V Loftus, Jean-Frederic Colombel, Ken Takeuchi, et al.Cell|September 7, 2005
Identification of an intestinal heme transporterMajid Shayeghi, Gladys O Latunde-Dada, Jonathan S Oakhill, et al.Intestinal Research|July 2, 2015
Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational StudyPaulo Gustavo Kotze, Antonino Spinelli, Rodolff Nunes da Silva, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 15, 2006
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trialHiroyuki Hanai, Takayuki Iida, Ken Takeuchi, et al.United European Gastroenterology Journal|April 15, 2017
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre studyTakayuki Yamamoto, Antonino Spinelli, Yasuo Suzuki, et al.Intestinal Research|June 4, 2025
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.Intestinal Research|July 14, 2025
Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational studyTaku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.Journal of Crohn'S & Colitis|March 31, 2015
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER databasePaulo Gustavo Kotze, Takayuki Yamamoto, Silvio Danese, et al.Pageof 10